These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 21842413)
1. Glycolysis inhibition by 2-deoxy-D-glucose reverts the metastatic phenotype in vitro and in vivo. Sottnik JL; Lori JC; Rose BJ; Thamm DH Clin Exp Metastasis; 2011 Dec; 28(8):865-75. PubMed ID: 21842413 [TBL] [Abstract][Full Text] [Related]
2. Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma. Eriksson JA; Wanka C; Burger MC; Urban H; Hartel I; von Renesse J; Harter PN; Mittelbronn M; Steinbach JP; Rieger J J Neurochem; 2018 Feb; 144(4):421-430. PubMed ID: 29178334 [TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target. Lapa B; Gonçalves AC; Jorge J; Alves R; Pires AS; Abrantes AM; Coucelo M; Abrunhosa A; Botelho MF; Nascimento-Costa JM; Sarmento-Ribeiro AB Med Oncol; 2020 Jul; 37(8):72. PubMed ID: 32725458 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin. Kim EH; Lee JH; Oh Y; Koh I; Shim JK; Park J; Choi J; Yun M; Jeon JY; Huh YM; Chang JH; Kim SH; Kim KS; Cheong JH; Kim P; Kang SG Neuro Oncol; 2017 Feb; 19(2):197-207. PubMed ID: 27571886 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of Src phosphorylation alters metastatic potential of osteosarcoma in vitro but not in vivo. Hingorani P; Zhang W; Gorlick R; Kolb EA Clin Cancer Res; 2009 May; 15(10):3416-22. PubMed ID: 19447875 [TBL] [Abstract][Full Text] [Related]
6. Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition. Ju R; Guo L; Li J; Zhu L; Yu X; Chen C; Chen W; Ye C; Zhang D Cancer Lett; 2016 Jan; 370(2):232-41. PubMed ID: 26522259 [TBL] [Abstract][Full Text] [Related]
7. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines. Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924 [TBL] [Abstract][Full Text] [Related]
8. p53 is an important factor for the radiosensitization effect of 2-deoxy-D-glucose. Sinthupibulyakit C; Grimes KR; Domann FE; Xu Y; Fang F; Ittarat W; St Clair DK; St Clair W Int J Oncol; 2009 Sep; 35(3):609-15. PubMed ID: 19639181 [TBL] [Abstract][Full Text] [Related]
9. Low-dose 2-deoxy glucose stabilises tolerogenic dendritic cells and generates potent in vivo immunosuppressive effects. Christofi M; Le Sommer S; Mölzer C; Klaska IP; Kuffova L; Forrester JV Cell Mol Life Sci; 2021 Mar; 78(6):2857-2876. PubMed ID: 33074350 [TBL] [Abstract][Full Text] [Related]
10. Effects of metabolic inhibition on conduction, Ca transients, and arrhythmia vulnerability in embryonic mouse hearts. Chen F; De Diego C; Xie LH; Yang JH; Klitzner TS; Weiss JN Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2472-8. PubMed ID: 17660398 [TBL] [Abstract][Full Text] [Related]
11. 2-Deoxyglucose induces the expression of thioredoxin interacting protein (TXNIP) by increasing O-GlcNAcylation - Implications for targeting the Warburg effect in cancer cells. Hong SY; Hagen T Biochem Biophys Res Commun; 2015 Oct; 465(4):838-44. PubMed ID: 26315267 [TBL] [Abstract][Full Text] [Related]
12. circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling. Wan J; Liu Y; Long F; Tian J; Zhang C Cancer Sci; 2021 May; 112(5):1707-1722. PubMed ID: 33369809 [TBL] [Abstract][Full Text] [Related]
13. One-stop radiotherapeutic targeting of primary and distant osteosarcoma to inhibit cancer progression and metastasis using 2DG-grafted graphene quantum dots. Tung FI; Zheng LJ; Hou KT; Chiang CS; Chen MH; Liu TY Nanoscale; 2020 Apr; 12(16):8809-8818. PubMed ID: 32250377 [TBL] [Abstract][Full Text] [Related]
14. A requirement for autophagy in HMGA2-induced metabolic reprogramming to support Cd-induced migration. Hasenbilige ; Mei J; Dlamini MB; Gao Z; Jiang L; Li Q; Geng C; Shi X; Liu Y; Kong Y; Cao J Toxicology; 2021 Oct; 462():152928. PubMed ID: 34481905 [TBL] [Abstract][Full Text] [Related]
15. Opposing effects of 2-deoxy-d-glucose on interictal- and ictal-like activity when K Nedergaard S; Andreasen M J Neurophysiol; 2018 May; 119(5):1912-1923. PubMed ID: 29412775 [TBL] [Abstract][Full Text] [Related]
16. Glycolysis inhibitor 2-deoxy-D-glucose suppresses carcinogen-induced rat hepatocarcinogenesis by restricting cancer cell metabolism. Wang Z; Zhang L; Zhang D; Sun R; Wang Q; Liu X Mol Med Rep; 2015 Mar; 11(3):1917-24. PubMed ID: 25394852 [TBL] [Abstract][Full Text] [Related]
17. Synergistic Anticancer Action of Lysosomal Membrane Permeabilization and Glycolysis Inhibition. Kosic M; Arsikin-Csordas K; Paunovic V; Firestone RA; Ristic B; Mircic A; Petricevic S; Bosnjak M; Zogovic N; Mandic M; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L J Biol Chem; 2016 Oct; 291(44):22936-22948. PubMed ID: 27587392 [TBL] [Abstract][Full Text] [Related]
18. Dynamic analysis of lung metastasis by mouse osteosarcoma LM8: VEGF is a candidate for anti-metastasis therapy. Tanaka T; Yui Y; Naka N; Wakamatsu T; Yoshioka K; Araki N; Yoshikawa H; Itoh K Clin Exp Metastasis; 2013 Apr; 30(4):369-79. PubMed ID: 23076771 [TBL] [Abstract][Full Text] [Related]
19. 2-deoxy-D-Glucose Synergizes with Doxorubicin or L-Buthionine Sulfoximine to Reduce Adhesion and Migration of Breast Cancer Cells. Mustafa EH; Mahmoud HT; Al-Hudhud MY; Abdalla MY; Ahmad IM; Yasin SR; Elkarmi AZ; Tahtamouni LH Asian Pac J Cancer Prev; 2015; 16(8):3213-22. PubMed ID: 25921122 [TBL] [Abstract][Full Text] [Related]
20. Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors. Wokoun U; Hellriegel M; Emons G; Gründker C Oncol Rep; 2017 Apr; 37(4):2418-2424. PubMed ID: 28350075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]